Ultracet and Breastfeeding
Clinical studies on Ultracet (tramadol/acetaminophen) and breastfeeding show that both components of the drug pass through breast milk. Although the acetaminophen component is not likely to cause problems, the tramadol component could cause drowsiness, seizures, or trouble breathing in a nursing infant. Before using Ultracet, breastfeeding women should talk to their healthcare providers about the potential risks.
Ultracet® (tramadol/acetaminophen) passes through breast milk in humans. If you are breastfeeding or are thinking about breastfeeding, talk with your healthcare provider before taking Ultracet. The manufacturer does not recommend that breastfeeding women take this medication.
The acetaminophen (Tylenol®) component of Ultracet passes through breast milk, but it is not likely to cause problems (see Tylenol and Breastfeeding). Tramadol hydrochloride (the opioid component) also passes through breast milk. It is possible that tramadol could cause problems (such as seizures, drowsiness, or trouble breathing) in a breastfed infant.
The manufacturer of Ultracet does not recommend using Ultracet to relieve pain after labor and delivery.
You should talk with your healthcare provider about Ultracet and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Ultracet and breastfeeding that is right for you.